Conformation-specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
Conformation-specific antibodies against multiple amyloid protofibril species from a single amyloid immunogen
复制标题
DOI:
10.1111/jcmm.14119
复制
发表时间:
2019-03-01
影响因子:
5.3
通讯作者:
Graham, W. Vallen
中科院分区:
文献类型:
--
作者:
Bonito-Oliva, Alessandra;Schedin-Weiss, Sophia;Graham, W. Vallen
We engineered and employed a chaperone-like amyloid-binding protein Nucleobindin 1 (NUCB1) to stabilize human islet amyloid polypeptide (hIAPP) protofibrils for use as immunogen in mice. We obtained multiple monoclonal antibody (mAb) clones that were reactive against hIAPP protofibrils. A secondary screen was carried out to identify clones that cross-reacted with amyloid beta-peptide (A beta 42) protofibrils, but not with A beta 40 monomers. These mAbs were further characterized in several in vitro assays, in immunohistological studies of a mouse model of Alzheimer's disease (AD) and in AD patient brain tissue. We show that mAbs obtained by immunizing mice with the NUCB1-hIAPP complex cross-react with A beta 42, specifically targeting protofibrils and inhibiting their further aggregation. In line with conformation-specific binding, the mAbs appear to react with an intracellular antigen in diseased tissue, but not with amyloid plaques. We hypothesize that the mAbs we describe here recognize a secondary or quaternary structural epitope that is common to multiple amyloid protofibrils. In summary, we report a method to create mAbs that are conformation-sensitive and sequence-independent and can target more than one type of protofibril species.